EPISODE · Jul 30, 2025 · 2 MIN
FDA急转弯，Sarepta基因疗法重返市场 -- 250729
from 生物科技 · host Rei
上周还在调查死亡病例，这周却放行？FDA对Sarepta的基因疗法Elevidys突然改口，宣布支持继续用于治疗可行走的杜氏肌营养不良（DMD）患者。这场监管急转弯，不仅拯救了Sarepta的核心市场，也让整个基因治疗领域重拾信心。本期快讯带你了解这起“生死72小时”的产业转折点，以及背后复杂的风险博弈。
Embed this episode
NOW PLAYING
FDA急转弯，Sarepta基因疗法重返市场 -- 250729
0:00
2:34
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 生物科技?
This episode is 2 minutes long.
When was this 生物科技 episode published?
This episode was published on July 30, 2025.
Can I download this 生物科技 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!